|
1
|
Wang H, Wang Z, Wu Q, Yuan Y, Cao W and
Zhang X: Regulatory T cells in ischemic stroke. CNS Neurosci Ther.
27:643–651. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lu M, Guo J, Wu B, Zhou Y, Wu M, Farzaneh
M and Khoshnam SE: Mesenchymal stem cell-mediated mitochondrial
transfer: A therapeutic approach for ischemic stroke. Transl Stroke
Res. 12:212–229. 2021. View Article : Google Scholar
|
|
3
|
Feng L, Han CX, Cao SY, Zhang HM and Wu
GY: Deficits in motor and cognitive functions in an adult mouse
model of hypoxia-ischemia induced stroke. Sci Rep. 10:206462020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barrington J, Lemarchand E and Allan SM: A
brain in flame; do inflammasomes and pyroptosis influence stroke
pathology? Brain Pathol. 27:205–212. 2017. View Article : Google Scholar
|
|
5
|
Lambertsen KL, Finsen B and Clausen BH:
Post-stroke inflammation-target or tool for therapy? Acta
Neuropathol. 137:693–714. 2019. View Article : Google Scholar
|
|
6
|
Andrabi SS, Parvez S and Tabassum H:
Ischemic stroke and mitochondria: Mechanisms and targets.
Protoplasma. 257:335–343. 2020. View Article : Google Scholar
|
|
7
|
Li X, Huang Z, Liu S, Zeng X, Xie J, Liu
C, Xiao H, Liu R, Li L and Zeng J: 3′-Daidzein sulfonate sodium
provides neuroprotection by promoting the expression of the alpha7
nicotinic acetylcholine receptor and suppressing inflammatory
responses in a rat model of focal cerebral ischemia. Am J Transl
Res. 10:3455–3464. 2018.
|
|
8
|
Mo Y, Sun YY and Liu KY: Autophagy and
inflammation in ischemic stroke. Neural Regen Res. 15:1388–1396.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jayaraj RL, Azimullah S, Beiram R, Jalal
FY and Rosenberg GA: Neuroinflammation: Friend and foe for ischemic
stroke. J Neuroinflammation. 16:1422019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vats K, Sarmah D, Kaur H, Wanve M, Kalia
K, Borah A, Dave KR, Yavagal DR and Bhattacharya P: Inflammasomes
in stroke: A triggering role for acid-sensing ion channels. Ann N Y
Acad Sci. 1431:14–24. 2018. View Article : Google Scholar
|
|
11
|
Forn-Cuni G, Meijer AH and Varela M:
Zebrafish in inflammasome research. Cells. 8:9012019. View Article : Google Scholar :
|
|
12
|
Ma C, Liu S, Zhang S, Xu T, Yu X, Gao Y,
Zhai C, Li C, Lei C, Fan S, et al: Evidence and perspective for the
role of the NLRP3 inflammasome signaling pathway in ischemic stroke
and its therapeutic potential (Review). Int J Mol Med.
42:2979–2990. 2018.
|
|
13
|
Xu Q, Zhao B, Ye Y, Li Y, Zhang Y, Xiong X
and Gu L: Relevant mediators involved in and therapies targeting
the inflammatory response induced by activation of the NLRP3
inflammasome in ischemic stroke. J Neuroinflammation. 18:1232021.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qian Y, Lyu Y, Jiang M, Tang B, Nie T and
Lu S: Human urinary kallidinogenase or edaravone combined with
butylphthalide in the treatment of acute ischemic stroke. Brain
Behav. 9:e014382019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Poh L, Kang SW, Baik SH, Ng GYQ, She DT,
Balaganapathy P, Dheen ST, Magnus T, Gelderblom M, Sobey CG, et al:
Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic
microglial death following ischemic stroke. Brain Behav Immun.
75:34–47. 2019. View Article : Google Scholar
|
|
16
|
Cao Y, Zhang H, Lu X, Wang J, Zhang X, Sun
S, Bao Z, Tian W, Ning S, Wang L and Cui L: Overexpression of
MicroRNA-9a-5p Ameliorates NLRP1 inflammasome-mediated ischemic
injury in rats following ischemic stroke. Neuroscience.
444:106–117. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu SY, Bian HJ, Shu S, Xia SN, Gu Y, Zhang
MJ, Xu Y and Cao X: AIM2 deletion enhances blood-brain barrier
integrity in experimental ischemic stroke. CNS Neurosci Ther.
27:1224–1237. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu JW and Lee MS: Mitochondria and the
NLRP3 inflammasome: Physiological and pathological relevance. Arch
Pharm Res. 39:1503–1518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He Y, Hara H and Nunez G: Mechanism and
regulation of NLRP3 inflammasome activation. Trends Biochem Sci.
41:1012–1021. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang YL, Wu HR, Zhang SS, Xiao HL, Yu J,
Ma YY, Zhang YD and Liu Q: Catalpol ameliorates depressive-like
behaviors in CUMS mice via oxidative stress-mediated NLRP3
inflammasome and neuroinflammation. Transl Psychiatry. 11:3532021.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Elliott EI and Sutterwala FS: Initiation
and perpetuation of NLRP3 inflammasome activation and assembly.
Immunol Rev. 265:35–52. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Savyuk M, Krivonosov M, Mishchenko T,
Gazaryan I, Ivanchenko M, Khristichenko A, Poloznikov A, Hushpulian
D, Nikulin S, Tonevitsky E, et al: Neuroprotective Effect of HIF
prolyl hydroxylase inhibition in an in vitro hypoxia model.
Antioxidants (Basel). 9:6622020. View Article : Google Scholar
|
|
23
|
Huber W, Zanner R, Schneider G, Schmid R
and Lahmer T: Assessment of regional perfusion and organ function:
Less and non-invasive techniques. Front Med (Lausanne). 6:502019.
View Article : Google Scholar
|
|
24
|
Wang W, Zhao F, Ma X, Perry G and Zhu X:
Mitochondria dysfunction in the pathogenesis of Alzheimer's
disease: Recent advances. Mol Neurodegener. 15:302020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li W, Kui L, Demetrios T, Gong X and Tang
M: A Glimmer of hope: Maintain mitochondrial homeostasis to
mitigate Alzheimer's disease. Aging Dis. 11:1260–1275. 2020.
View Article : Google Scholar :
|
|
26
|
Ham PR and Raju R: Mitochondrial function
in hypoxic ischemic injury and influence of aging. Prog Neurobiol.
157:92–116. 2017. View Article : Google Scholar
|
|
27
|
Liu Y, Lin J, Wu X, Guo X, Sun H, Yu B,
Shen J, Bai J, Chen Z, Yang H, et al: Aspirin-mediated attenuation
of intervertebral disc degeneration by ameliorating reactive oxygen
species in vivo and in vitro. Oxid Med Cell Longev.
2019:71898542019. View Article : Google Scholar
|
|
28
|
Anzell AR, Maizy R, Przyklenk K and
Sanderson TH: Mitochondrial quality control and disease: Insights
into ischemia-reperfusion injury. Mol Neurobiol. 55:2547–2564.
2018. View Article : Google Scholar
|
|
29
|
Babenko VA, Silachev DN, Popkov VA, Zorova
LD, Pevzner IB, Plotnikov EY, Sukhikh GT and Zorov DB: Miro1
enhances mitochondria transfer from multipotent mesenchymal stem
cells (MMSC) to neural cells and improves the efficacy of cell
recovery. Molecules. 23:6872018. View Article : Google Scholar :
|
|
30
|
Mondal NK, Behera J, Kelly KE, George AK,
Tyagi PK and Tyagi N: Tetrahydrocurcumin epigenetically mitigates
mitochondrial dysfunction in brain vasculature during ischemic
stroke. Neurochem Int. 122:120–138. 2019. View Article : Google Scholar :
|
|
31
|
Andrabi SS, Ali M, Tabassum H, Parveen S
and Parvez S: Pramipexole prevents ischemic cell death via
mitochondrial pathways in ischemic stroke. Dis Model Mech.
12:dmm0338602019. View Article : Google Scholar :
|
|
32
|
Chen N, Zhou Z, Li J, Li B, Feng J, He D,
Luo Y, Zheng X, Luo J and Zhang J: 3-n-butylphthalide exerts
neuroprotective effects by enhancing anti-oxidation and attenuating
mitochondrial dysfunction in an in vitro model of ischemic stroke.
Drug Des Devel Ther. 12:4261–4271. 2018. View Article : Google Scholar :
|
|
33
|
Peng J, Wang H, Gong Z, Li X, He L, Shen
Q, Pan J and Peng Y: Idebenone attenuates cerebral inflammatory
injury in ischemia and reperfusion via dampening NLRP3 inflammasome
activity. Mol Immunol. 123:74–87. 2020. View Article : Google Scholar
|
|
34
|
Luan Y, Yang D, Zhang Z, Bie X, Zhao H,
Wang Y, Liu Y, Yang S, Zhou B, Xu Y, et al: Association study
between genetic variation in whole mitochondrial genome and
ischemic stroke. J Mol Neurosci. 71:2152–2162. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sarmah D, Datta A, Raut S, Sarkar A, Shah
B, Bohra M, Singh U, Jagtap P, Baidya F, Kalia K, et al: The role
of inflammasomes in atherosclerosis and stroke pathogenesis. Curr
Pharm Des. 26:4234–4245. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Martynov MY and Gusev EI: Current
knowledge on the neuroprotective and neuroregenerative properties
of citicoline in acute ischemic stroke. J Exp Pharmacol. 7:17–28.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bissen D, Foss F and Acker-Palmer A: AMPA
receptors and their minions: Auxiliary proteins in AMPA receptor
trafficking. Cell Mol Life Sci. 76:2133–2169. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Y, Qin C, Huang J, Tang X, Liu C,
Huang K, Xu J, Guo G, Tong A and Zhou L: The role of astrocytes in
oxidative stress of central nervous system: A mixed blessing. Cell
Prolif. 53:e127812020. View Article : Google Scholar :
|
|
39
|
Wen B, Xu K, Huang R, Jiang T, Wang J,
Chen J, Chen J and He B: Preserving mitochondrial function by
inhibiting GRP75 ameliorates neuron injury under ischemic stroke.
Mol Med Rep. 25:1652022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu D, Gharavi R, Pitta M, Gleichmann M
and Mattson MP: Nicotinamide prevents NAD+ depletion and protects
neurons against excitotoxicity and cerebral ischemia: NAD+
consumption by SIRT1 may endanger energetically compromised
neurons. Neuromolecular Med. 11:28–42. 2009. View Article : Google Scholar :
|
|
41
|
Misawa T, Takahama M, Kozaki T, Lee H, Zou
J, Saitoh T and Akira S: Microtubule-driven spatial arrangement of
mitochondria promotes activation of the NLRP3 inflammasome. Nat
Immunol. 14:454–460. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li S, Wang T, Zhai L, Ge K, Zhao J, Cong W
and Guo Y: Picroside II exerts a neuroprotective effect by
inhibiting mPTP permeability and EndoG release after cerebral
ischemia/reperfusion injury in rats. J Mol Neurosci. 64:144–155.
2018. View Article : Google Scholar
|
|
43
|
Zheng W, Talley WL, Holstein DM, Wewer J
and Lechleiter JD: P2Y1R-initiated, IP3R-dependent stimulation of
astrocyte mitochondrial metabolism reduces and partially reverses
ischemic neuronal damage in mouse. J Cereb Blood Flow Metab.
33:600–711. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bonora M, Bononi A, De Marchi E, Giorgi C,
Lebiedzinska M, Marchi S, Patergnani S, Rimessi A, Suski JM,
Wojtala A, et al: Role of the c subunit of the FO ATP synthase in
mitochondrial permeability transition. Cell Cycle. 12:674–683.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou H, Hu S, Jin Q, Shi C, Zhang Y, Zhu
P, Ma Q, Tian F and Chen Y: Mff-Dependent mitochondrial fission
contributes to the pathogenesis of cardiac microvasculature
ischemia/reperfusion injury via induction of mROS-mediated
cardiolipin oxidation and HK2/VDAC1 disassociation-involved mPTP
opening. J Am Heart Assoc. 6:e0053282017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jin X, Zhang J, An T, Zhao H, Fu W, Li D,
Liu S, Cao X and Liu B: A Genome-wide screen in saccharomyces
cerevisiae reveals a critical role for oxidative phosphorylation in
cellular tolerance to lithium hexafluorophosphate. Cells.
10:8882021. View Article : Google Scholar :
|
|
47
|
He J, Liu J, Huang Y, Zhuo Y, Chen W, Duan
D, Tang X, Lu M and Hu Z: Olfactory mucosa mesenchymal stem cells
alleviate cerebral ischemia/reperfusion injury via Golgi apparatus
secretory pathway Ca2+-ATPase isoform1. Front Cell Dev
Biol. 8:5865412020. View Article : Google Scholar
|
|
48
|
Chen M, Wang M, Yang Q, Wang M, Wang Z,
Zhu Y, Zhang Y, Wang C, Jia Y, Li Y and Wen A: Antioxidant effects
of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in
combination on isoproterenol-induced myocardial injury in rats. Int
J Mol Med. 37:1501–1510. 2016. View Article : Google Scholar :
|
|
49
|
Wang C, Hao J, Liu X, Li C, Yuan X, Lee
RJ, Bai T and Wang D: Isoforsythiaside attenuates Alzheimer's
disease via regulating mitochondrial function through the PI3K/AKT
pathway. Int J Mol Sci. 21:56872020. View Article : Google Scholar
|
|
50
|
Wang T, Wang F, Yu L and Li Z: Nobiletin
alleviates cerebral ischemic-reperfusion injury via MAPK signaling
pathway. Am J Transl Res. 11:5967–5977. 2019.PubMed/NCBI
|
|
51
|
Zhao Q, Zhang C, Wang X, Chen L, Ji H and
Zhang Y: (S)-ZJM-289, a nitric oxide-releasing derivative of
3-n-butylphthalide, protects against ischemic neuronal injury by
attenuating mitochondrial dysfunction and associated cell death.
Neurochem Int. 60:134–144. 2012. View Article : Google Scholar
|
|
52
|
Tan YQ, Zhang X, Zhang S, Zhu T, Garg M,
Lobie PE and Pandey V: Mitochondria: The metabolic switch of
cellular oncogenic transformation. Biochim Biophys Acta Rev Cancer.
1876:1885342021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jahani-Asl A, Cheung EC, Neuspiel M,
MacLaurin JG, Fortin A, Park DS, McBride HM and Slack RS: Mitofusin
2 protects cerebellar granule neurons against injury-induced cell
death. J Biol Chem. 282:23788–23798. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
McGahan L, Hakim AM and Robertson GS:
Hippocampal Myc and p53 expression following transient global
ischemia. Brain Res Mol Brain Res. 56:133–145. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li Y and Liu X: Novel insights into the
role of mitochondrial fusion and fission in cardiomyocyte apoptosis
induced by ischemia/reperfusion. J Cell Physiol. 233:5589–5597.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Grohm J, Kim SW, Mamrak U, Tobaben S,
Cassidy-Stone A, Nunnari J, Plesnila N and Culmsee C: Inhibition of
Drp1 provides neuroprotection in vitro and in vivo. Cell Death
Differ. 19:1446–1458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhao YX, Cui M, Chen SF, Dong Q and Liu
XY: Amelioration of ischemic mitochondrial injury and Bax-dependent
outer membrane permeabilization by Mdivi-1. CNS Neurosci Ther.
20:528–538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang J, Xiong S, Xie C, Markesbery WR and
Lovell MA: Increased oxidative damage in nuclear and mitochondrial
DNA in Alzheimer's disease. J Neurochem. 93:953–962. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
West AP and Shadel GS: Mitochondrial DNA
in innate immune responses and inflammatory pathology. Nat Rev
Immunol. 17:363–375. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Guo S, Geng X, Lee H and Ding Y:
Phenothiazine inhibits neuroinflammation and inflammasome
activation independent of hypothermia after ischemic stroke. Mol
Neurobiol. 58:6136–6152. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lian L, Zhang Y, Liu L, Yang L, Cai Y,
Zhang J and Xu S: Neuroinflammation in ischemic stroke: Focus on
MicroRNA-mediated polarization of microglia. Front Mol Neurosci.
13:6124392020. View Article : Google Scholar
|
|
62
|
Shaheryar ZA, Khan MA, Adnan CS, Zaidi AA,
Hanggi D and Muhammad S: Neuroinflammatory triangle presenting
novel pharmacological targets for ischemic brain injury. Front
Immunol. 12:7486632021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Xue Y, Nie D, Wang LJ, Qiu HC, Ma L, Dong
MX, Tu WJ and Zhao J: Microglial polarization: Novel therapeutic
strategy against ischemic stroke. Aging Dis. 12:466–479. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wang L, Yu CC, Liu XY, Deng XN, Tian Q and
Du YJ: Epigenetic modulation of microglia function and phenotypes
in neurodegenerative diseases. Neural Plast. 2021:99126862021.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ponsaerts L, Alders L, Schepers M, de
Oliveira RMW, Prickaerts J, Vanmierlo T and Bronckaers A:
Neuroinflammation in ischemic stroke: Inhibition of cAMP-Specific
phosphodiesterases (PDEs) to the rescue. Biomedicines. 9:7032021.
View Article : Google Scholar :
|
|
66
|
Guan X, Zhang Y, Gareev I, Beylerli O, Li
X, Lu X, Lv L and Hai X: MiR-499a prevents astrocytes mediated
inflammation in ischemic stroke by targeting PTEN. Noncoding RNA
Res. 6:146–152. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Franke M, Bieber M, Kraft P, Weber A,
Stoll G and Schuhmann MK: The NLRP3 inflammasome drives
inflammation in ischemia/reperfusion injury after transient middle
cerebral artery occlusion in mice. Brain Behav Immun. 92:223–233.
2021. View Article : Google Scholar
|
|
68
|
Gritsenko A, Green JP, Brough D and
Lopez-Castejon G: Mechanisms of NLRP3 priming in inflammaging and
age related diseases. Cytokine Growth Factor Rev. 55:15–25. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Xu S, Li X, Liu Y, Xia Y, Chang R and
Zhang C: Inflammasome inhibitors: Promising therapeutic approaches
against cancer. J Hematol Oncol. 12:642019. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Shim DW and Lee KH: Posttranslational
regulation of the NLR family pyrin domain-containing 3
inflammasome. Front Immunol. 9:10542018. View Article : Google Scholar :
|
|
71
|
Han S, Lear TB, Jerome JA, Rajbhandari S,
Snavely CA, Gulick DL, Gibson KF, Zou C, Chen BB and Mallampalli
RK: Lipopolysaccharide primes the NALP3 inflammasome by inhibiting
its ubiquitination and degradation mediated by the SCFFBXL2 E3
ligase. J Biol Chem. 290:18124–18133. 2015. View Article : Google Scholar :
|
|
72
|
Swanson KV, Deng M and Ting JP: The NLRP3
inflammasome: Molecular activation and regulation to therapeutics.
Nat Rev Immunol. 19:477–489. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Susjan P, Roskar S and Hafner-Bratkovic I:
The mechanism of NLRP3 inflammasome initiation: Trimerization but
not dimerization of the NLRP3 pyrin domain induces robust
activation of IL-1beta. Biochem Biophys Res Commun. 483:823–828.
2017. View Article : Google Scholar
|
|
74
|
Lu A, Magupalli VG, Ruan J, Yin Q,
Atianand MK, Vos MR, Schröder GF, Fitzgerald KA, Wu H and Egelman
EH: Unified polymerization mechanism for the assembly of
ASC-dependent inflammasomes. Cell. 156:1193–1206. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Boucher D, Monteleone M, Coll RC, Chen KW,
Ross CM, Teo JL, Gomez GA, Holley CL, Bierschenk D, Stacey KJ, et
al: Caspase-1 self-cleavage is an intrinsic mechanism to terminate
inflammasome activity. J Exp Med. 215:827–840. 2018. View Article : Google Scholar :
|
|
76
|
Dick MS, Sborgi L, Ruhl S, Hiller S and
Broz P: ASC filament formation serves as a signal amplification
mechanism for inflammasomes. Nat Commun. 7:119292016. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lu L, Lu Q, Chen W, Li J, Li C and Zheng
Z: Vitamin D3 protects against diabetic retinopathy by inhibiting
high-glucose-induced activation of the ROS/TXNIP/NLRP3 inflammasome
pathway. J Diabetes Res. 2018:81935232018. View Article : Google Scholar :
|
|
78
|
Ratajczak MZ, Bujko K, Cymer M, Thapa A,
Adamiak M, Ratajczak J, Abdel-Latif AK and Kucia M: The Nlrp3
inflammasome as a 'rising star' in studies of normal and malignant
hematopoiesis. Leukemia. 34:1512–1523. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Gao L, Dong Q, Song Z, Shen F, Shi J and
Li Y: NLRP3 inflammasome: A promising target in ischemic stroke.
Inflamm Res. 66:17–24. 2017. View Article : Google Scholar
|
|
80
|
Liu H, Wu X, Luo J, Zhao L, Li X, Guo H,
Bai H, Cui W, Guo W, Feng D and Qu Y: Adiponectin peptide
alleviates oxidative stress and NLRP3 inflammasome activation after
cerebral ischemia-reperfusion injury by regulating AMPK/GSK-3beta.
Exp Neurol. 329:1133022020. View Article : Google Scholar
|
|
81
|
Zhao J, Piao X, Wu Y, Liang S, Han F,
Liang Q, Shao S and Zhao D: Cepharanthine attenuates cerebral
ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced
inflammation and oxidative stress via inhibiting 12/15-LOX
signaling. Biomed Pharmacother. 127:1101512020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Yang F, Wang Z, Wei X, Han H, Meng X,
Zhang Y, Shi W, Li F, Xin T, Pang Q and Yi F: NLRP3 deficiency
ameliorates neurovascular damage in experimental ischemic stroke. J
Cereb Blood Flow Metab. 34:660–667. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Feng YS, Tan ZX, Wang MM, Xing Y, Dong F
and Zhang F: Inhibition of NLRP3 inflammasome: A prospective target
for the treatment of ischemic stroke. Front Cell Neurosci.
14:1552020. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Shi M, Chen J, Liu T, Dai W, Zhou Z, Chen
L and Xie Y: Protective effects of remimazolam on cerebral
ischemia/reperfusion injury in rats by inhibiting of NLRP3
inflammasome-dependent pyroptosis. Drug Des Devel Ther. 16:413–423.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Ye Y, Jin T, Zhang X, Zeng Z, Ye B, Wang
J, Zhong Y, Xiong X and Gu L: Meisoindigo protects against focal
cerebral ischemia-reperfusion injury by inhibiting NLRP3
inflammasome activation and regulating microglia/macrophage
polarization via TLR4/NF-κB signaling pathway. Front Cell Neurosci.
13:5532019. View Article : Google Scholar
|
|
86
|
He Z, Ning N, Zhou Q, Khoshnam SE and
Farzaneh M: Mitochondria as a therapeutic target for ischemic
stroke. Free Radic Biol Med. 146:45–58. 2020. View Article : Google Scholar
|
|
87
|
Chen Y, Zhou Z and Min W: Mitochondria,
oxidative stress and innate immunity. Front Physiol. 9:14872018.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Meyers AK and Zhu X: The NLRP3
inflammasome: Metabolic regulation and contribution to
inflammaging. Cells. 9:18082020. View Article : Google Scholar :
|
|
89
|
Bauernfeind F, Bartok E, Rieger A, Franchi
L, Nunez G and Hornung V: Cutting edge: Reactive oxygen species
inhibitors block priming, but not activation, of the NLRP3
inflammasome. J Immunol. 187:613–617. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Paik S, Kim JK, Silwal P, Sasakawa C and
Jo EK: An update on the regulatory mechanisms of NLRP3 inflammasome
activation. Cell Mol Immunol. 18:1141–1160. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Ren GM, Li J, Zhang XC, Wang Y, Xiao Y,
Zhang XY, Liu X, Zhang W, Ma WB, Zhang J, et al: Pharmacological
targeting of NLRP3 deubiquitination for treatment of
NLRP3-associated inflammatory diseases. Sci Immunol.
6:eabe29332021. View Article : Google Scholar
|
|
92
|
Ren JD, Wu XB, Jiang R, Hao DP and Liu Y:
Molecular hydrogen inhibits lipopolysaccharide-triggered NLRP3
inflammasome activation in macrophages by targeting the
mitochondrial reactive oxygen species. Biochim Biophys Acta.
1863:50–55. 2016. View Article : Google Scholar
|
|
93
|
Wang Y, Shi P, Chen Q, Huang Z, Zou D,
Zhang J, Gao X and Lin Z: Mitochondrial ROS promote macrophage
pyroptosis by inducing GSDMD oxidation. J Mol Cell Biol.
11:1069–1082. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Heid ME, Keyel PA, Kamga C, Shiva S,
Watkins SC and Salter RD: Mitochondrial reactive oxygen species
induces NLRP3-dependent lysosomal damage and inflammasome
activation. J Immunol. 191:5230–5238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Qiu Z, He Y, Ming H, Lei S, Leng Y and Xia
ZY: Lipopolysaccharide (LPS) aggravates high glucose- and
hypoxia/reoxygenation-induced injury through activating
ROS-Dependent NLRP3 inflammasome-mediated pyroptosis in H9C2
cardiomyocytes. J Diabetes Res. 2019:81518362019. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Liu X, Zhang X, Ding Y, Zhou W, Tao L, Lu
P, Wang Y and Hu R: Nuclear factor E2-Related Factor-2 negatively
regulates NLRP3 inflammasome activity by inhibiting reactive oxygen
species-induced NLRP3 priming. Antioxid Redox Signal. 26:28–43.
2017. View Article : Google Scholar :
|
|
97
|
Juliana C, Fernandes-Alnemri T, Kang S,
Farias A, Qin F and Alnemri ES: Non-transcriptional priming and
deubiquitination regulate NLRP3 inflammasome activation. J Biol
Chem. 287:36617–36622. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Krysko DV, Agostinis P, Krysko O, Garg AD,
Bachert C, Lambrecht BN and Vandenabeele P: Emerging role of
damage-associated molecular patterns derived from mitochondria in
inflammation. Trends Immunol. 32:157–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Arias-Cartin R, Grimaldi S, Arnoux P,
Guigliarelli B and Magalon A: Cardiolipin binding in bacterial
respiratory complexes: Structural and functional implications.
Biochim Biophys Acta. 1817:1937–1949. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Ji J, Baart S, Vikulina AS, Clark RS,
Anthonymuthu TS, Tyurin VA, Du L, St Croix CM, Tyurina YY, Lewis J,
et al: Deciphering of mitochondrial cardiolipin oxidative signaling
in cerebral ischemia-reperfusion. J Cereb Blood Flow Metab.
35:319–328. 2015. View Article : Google Scholar :
|
|
101
|
Liu J, Wang T, He K, Xu M and Gong JP:
Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis
through suppressing NLRP3 inflammasome activation. Eur Rev Med
Pharmacol Sci. 23:8158–8167. 2019.PubMed/NCBI
|
|
102
|
Szeto HH, Liu S, Soong Y, Seshan SV,
Cohen-Gould L, Manichev V, Feldman LC and Gustafsson T:
Mitochondria protection after acute ischemia prevents prolonged
upregulation of IL-1β and IL-18 and arrests CKD. J Am Soc Nephrol.
28:1437–1449. 2017. View Article : Google Scholar
|
|
103
|
Carinci M, Vezzani B, Patergnani S,
Ludewig P, Lessmann K, Magnus T, Casetta I, Pugliatti M, Pinton P
and Giorgi C: Different roles of mitochondria in cell death and
inflammation: Focusing on mitochondrial quality control in ischemic
stroke and reperfusion. Biomedicines. 9:1692021. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Yabal M, Calleja DJ, Simpson DS and Lawlor
KE: Stressing out the mitochondria: Mechanistic insights into NLRP3
inflammasome activation. J Leukoc Biol. 105:377–399. 2019.
View Article : Google Scholar
|
|
105
|
Englander EW, Greeley GJ, Wang G,
Perez-Polo JR and Lee HM: Hypoxia-induced mitochondrial and nuclear
DNA damage in the rat brain. J Neurosci Res. 58:262–269. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Shimada K, Crother TR, Karlin J, Dagvadorj
J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, et
al: Oxidized mitochondrial DNA activates the NLRP3 inflammasome
during apoptosis. Immunity. 36:401–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Nakahira K, Haspel JA, Rathinam VA, Lee
SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim
HP, et al: Autophagy proteins regulate innate immune responses by
inhibiting the release of mitochondrial DNA mediated by the NALP3
inflammasome. Nat Immunol. 12:222–2230. 2011. View Article : Google Scholar
|
|
108
|
Lara PC, Macias-Verde D and Burgos-Burgos
J: Age-induced NLRP3 inflammasome over-activation increases
lethality of SARS-CoV-2 pneumonia in elderly patients. Aging Dis.
11:756–762. 2020. View Article : Google Scholar :
|
|
109
|
Fu L, Zhang DX, Zhang LM, Song YC, Liu FH,
Li Y, Wang XP, Zheng WC, Wang XD, Gui CX, et al: Exogenous carbon
monoxide protects against mitochondrial DNAinduced hippocampal
pyroptosis in a model of hemorrhagic shock and resuscitation. Int J
Mol Med. 45:1176–1186. 2020.
|
|
110
|
Simon R, Meller R, Yang T, Pearson A and
Wilson G: Enhancing base excision repair of mitochondrial DNA to
reduce ischemic injury following reperfusion. Transl Stroke Res.
10:664–671. 2019. View Article : Google Scholar :
|
|
111
|
Gomez-Suaga P, Bravo-San PJ, Gonzalez-Polo
RA, Fuentes JM and Niso-Santano M: ER-mitochondria signaling in
Parkinson's disease. Cell Death Dis. 9:3372018. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Tubbs E, Theurey P, Vial G, Bendridi N,
Bravard A, Chauvin MA, Ji-Cao J, Zoulim F, Bartosch B, Ovize M, et
al: Mitochondria-associated endoplasmic reticulum membrane (MAM)
integrity is required for insulin signaling and is implicated in
hepatic insulin resistance. Diabetes. 63:3279–3294. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Bravo R, Vicencio JM, Parra V, Troncoso R,
Munoz JP, Bui M, Quiroga C, Rodriguez AE, Verdejo HE, Ferreira J,
et al: Increased ER-mitochondrial coupling promotes mitochondrial
respiration and bioenergetics during early phases of ER stress. J
Cell Sci. 24:2143–2152. 2011. View Article : Google Scholar
|
|
114
|
Elliott EI, Miller AN, Banoth B, Iyer SS,
Stotland A, Weiss JP, Gottlieb RA, Sutterwala FS and Cassel SL:
Cutting Edge: Mitochondrial assembly of the NLRP3 inflammasome
complex is initiated at priming. J Immunol. 200:3047–3052. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Hamilton C and Anand PK: Right place,
right time: Localisation and assembly of the NLRP3 inflammasome.
F1000Res. 8:F1000 Faculty Rev-676. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhou R, Yazdi AS, Menu P and Tschopp J: A
role for mitochondria in NLRP3 inflammasome activation. Nature.
469:221–225. 2011. View Article : Google Scholar
|
|
117
|
Gu J, Zhang T, Guo J, Chen K, Li H and
Wang J: PINK1 activation and translocation to
mitochondria-associated membranes mediates mitophagy and protects
against hepatic ischemia/reperfusion injury. Shock. 54:783–793.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Spescha RD, Klohs J, Semerano A, Giacalone
G, Derungs RS, Reiner MF, Rodriguez Gutierrez D, Mendez-Carmona N,
Glanzmann M, Savarese G, et al: Post-ischaemic silencing of p66Shc
reduces ischaemia/reperfusion brain injury and its expression
correlates to clinical outcome in stroke. Eur Heart J.
36:1590–1600. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Thoudam T, Jeon JH, Ha CM and Lee IK: Role
of Mitochondria-Associated endoplasmic reticulum membrane in
inflammation-mediated metabolic diseases. Mediators Inflamm.
2016:18514202016. View Article : Google Scholar
|
|
120
|
Fu MM and Holzbaur EL: Integrated
regulation of motor-driven organelle transport by scaffolding
proteins. Trends Cell Biol. 24:564–574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Place DE and Kanneganti TD: Recent
advances in inflammasome biology. Curr Opin Immunol. 50:32–38.
2018. View Article : Google Scholar :
|
|
122
|
Harkcom WT, Ghosh AK, Sung MS, Matov A,
Brown KD, Giannakakou P and Jaffrey SR: NAD+ and SIRT3 control
microtubule dynamics and reduce susceptibility to antimicrotubule
agents. Proc Natl Acad Sci USA. 111:E2443–E2452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Nasoohi S, Ismael S and Ishrat T:
Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and
Neurodegenerative Diseases: Regulation and Implication. Mol
Neurobiol. 55:7900–7920. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Nagaraj K, Lapkina-Gendler L, Sarfstein R,
Gurwitz D, Pasmanik-Chor M, Laron Z, Yakar S and Werner H:
Identification of thioredoxin-interacting protein (TXNIP) as a
downstream target for IGF1 action. Proc Natl Acad Sci USA.
115:1045–1050. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zhou R, Tardivel A, Thorens B, Choi I and
Tschopp J: Thioredoxin-interacting protein links oxidative stress
to inflammasome activation. Nat Immunol. 11:136–140. 2010.
View Article : Google Scholar
|
|
126
|
Fann DY, Lee SY, Manzanero S, Chunduri P,
Sobey CG and Arumugam TV: Pathogenesis of acute stroke and the role
of inflammasomes. Ageing Res Rev. 12:941–966. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Han Y, Xu X, Tang C, Gao P, Chen X, Xiong
X, Yang M, Yang S, Zhu X, Yuan S, et al: Reactive oxygen species
promote tubular injury in diabetic nephropathy: The role of the
mitochondrial ros-txnip-nlrp3 biological axis. Redox Biol.
16:32–46. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Wang BF and Yoshioka J: The Emerging role
of thioredoxin-interacting protein in myocardial
ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther.
22:219–229. 2017. View Article : Google Scholar :
|
|
129
|
Schafer MK, Pfeiffer A, Jaeckel M, Pouya
A, Dolga AM and Methner A: Regulators of mitochondrial Ca(2+)
homeostasis in cerebral ischemia. Cell Tissue Res. 357:395–405.
2014. View Article : Google Scholar
|
|
130
|
Missiroli S, Patergnani S, Caroccia N,
Pedriali G, Perrone M, Previati M, Wieckowski MR and Giorgi C:
Mitochondria-associated membranes (MAMs) and inflammation. Cell
Death Dis. 9:3292018. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Lee GS, Subramanian N, Kim AI,
Aksentijevich I, Goldbach-Mansky R, Sacks DB, Germain RN, Kastner
DL and Chae JJ: The calcium-sensing receptor regulates the NLRP3
inflammasome through Ca2+ and cAMP. Nature. 492:123–127. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Wang C, Jia Q, Sun C and Jing C: Calcium
sensing receptor contribute to early brain injury through the
CaMKII/NLRP3 pathway after subarachnoid hemorrhage in mice. Biochem
Biophys Res Commun. 530:651–657. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Triantafilou K, Hughes TR, Triantafilou M
and Morgan BP: The complement membrane attack complex triggers
intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation.
J Cell Sci. 126:2903–2913. 2013.PubMed/NCBI
|
|
134
|
Murakami T, Ockinger J, Yu J, Byles V,
McColl A, Hofer AM and Horng T: Critical role for calcium
mobilization in activation of the NLRP3 inflammasome. Proc Natl
Acad Sci USA. 109:11282–11287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Pan T, Zhu QJ, Xu LX, Ding X, Li JQ, Sun
B, Hua J and Feng X: Knocking down TRPM2 expression reduces cell
injury and NLRP3 inflammasome activation in PC12 cells subjected to
oxygen-glucose deprivation. Neural Regen Res. 15:2154–2161. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF,
Mao L, Xia YP, Jin HJ, Li YN, You MF, et al: Microglia-derived
TNF-α mediates endothelial necroptosis aggravating blood
brain-barrier disruption after ischemic stroke. Cell Death Dis.
10:4872019. View Article : Google Scholar
|
|
137
|
Wang H, Sun L, Su L, Rizo J, Liu L, Wang
LF, Wang FS and Wang X: Mixed lineage kinase domain-like protein
MLKL causes necrotic membrane disruption upon phosphorylation by
RIP3. Mol Cell. 54:133–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
He S and Wang X: RIP kinases as modulators
of inflammation and immunity. Nat Immunol. 19:912–922. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Zeng F, Chen X, Cui W, Wen W, Lu F, Sun X,
Ma D, Yuan Y, Li Z, Hou N, et al: RIPK1 Binds MCU to mediate
induction of mitochondrial Ca2+ uptake and promotes
colorectal oncogenesis. Cancer Res. 78:2876–2885. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Jiao Y, Wang J, Zhang H, Cao Y, Qu Y,
Huang S, Kong X, Song C, Li J, Li Q, et al: Inhibition of
microglial receptor-interacting protein kinase 1 ameliorates
neuroinflammation following cerebral ischaemic stroke. J Cell Mol
Med. 24:12585–12598. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Deng XX, Li SS and Sun FY: Necrostatin-1
prevents necroptosis in brains after ischemic stroke via inhibition
of RIPK1-Mediated RIPK3/MLKL signaling. Aging Dis. 10:807–817.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Park S, Won JH, Hwang I, Hong S, Lee HK
and Yu JW: Defective mitochondrial fission augments NLRP3
inflammasome activation. Sci Rep. 5:154892015. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Xie JH, Li YY and Jin J: The essential
functions of mitochondrial dynamics in immune cells. Cell Mol
Immunol. 17:712–721. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Ren L, Chen X, Chen X, Li J, Cheng B and
Xia J: Mitochondrial dynamics: Fission and fusion in fate
determination of mesenchymal stem cells. Front Cell Dev Biol.
8:5800702020. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Szabadkai G, Simoni AM, Chami M,
Wieckowski MR, Youle RJ and Rizzuto R: Drp-1-dependent division of
the mitochondrial network blocks intraorganellar Ca2+ waves and
protects against Ca2+-mediated apoptosis. Mol Cell. 16:59–68. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Flippo KH, Gnanasekaran A, Perkins GA,
Ajmal A, Merrill RA, Dickey AS, Taylor SS, McKnight GS, Chauhan AK,
Usachev YM and Strack S: AKAP1 protects from cerebral ischemic
stroke by inhibiting Drp1-dependent mitochondrial fission. J
Neurosci. 38:8233–8242. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Guo M, Wang X, Zhao Y, Yang Q, Ding H,
Dong Q, Chen X and Cui M: Ketogenic diet improves brain ischemic
tolerance and inhibits NLRP3 inflammasome activation by preventing
Drp1-Mediated mitochondrial fission and endoplasmic reticulum
stress. Front Mol Neurosci. 11:862018. View Article : Google Scholar :
|
|
148
|
He J and Zhang X: miR-668 inhibitor
attenuates mitochondrial membrane potential and protects against
neuronal apoptosis in cerebral ischemic stroke. Folia Neuropathol.
58:22–29. 2020. View Article : Google Scholar
|
|
149
|
Zhang X, Yan H, Yuan Y, Gao J, Shen Z,
Cheng Y, Shen Y, Wang RR, Wang X, Hu WW, et al: Cerebral
ischemia-reperfusion-induced autophagy protects against neuronal
injury by mitochondrial clearance. Autophagy. 9:1321–1333. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Wang J, Yu S, Li J, Li H, Jiang H, Xiao P,
Pan Y, Zheng J, Yu L and Jiang J: Protective role of
N-acetyl-l-tryptophan against hepatic ischemia-reperfusion injury
via the RIP2/caspase-1/IL-1beta signaling pathway. Pharm Biol.
57:385–391. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Wang Y, Tian J, Qiao X, Su X, Mi Y, Zhang
R and Li R: Intermedin protects against renal ischemia-reperfusion
injury by inhibiting endoplasmic reticulum stress. BMC Nephrol.
16:1692015. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
He Q, Li Z, Meng C, Wu J, Zhao Y and Zhao
J: Parkin-dependent mitophagy is required for the inhibition of
ATF4 on NLRP3 inflammasome activation in cerebral
ischemia-reperfusion injury in rats. Cells. 8:8972019. View Article : Google Scholar :
|
|
153
|
Yang J, Chen Y and Pang Y: Occurrence of
mitochondrial autophagy and nlrp3 inflammatory bodies in cerebral
ischemia-reperfusion injury and its correlation with
neuroinflammatory response. Acta Medica Mediterranea. 37:1033–1037.
2021.
|
|
154
|
Su SH, Wu YF, Lin Q, Wang DP and Hai J:
URB597 protects against NLRP3 inflammasome activation by inhibiting
autophagy dysfunction in a rat model of chronic cerebral
hypoperfusion. J Neuroinflammation. 16:2602019. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Fan Y, Zhu S, Wang J, Zhao Y and Wang X:
Propofol protects against oxygen/glucose deprivationinduced cell
injury via gap junction inhibition in astrocytes. Mol Med Rep.
22:2896–2904. 2020.PubMed/NCBI
|
|
156
|
Cai Y, Guo H, Fan Z, Zhang X, Wu D, Tang
W, Gu T, Wang S, Yin A, Tao L, et al: Glycogenolysis is crucial for
astrocytic glycogen accumulation and brain damage after reperfusion
in ischemic stroke. iScience. 23:1011362020. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Gao L, Liu F, Hou PP, Manaenko A, Xiao ZP,
Wang F, Xu TL and Hu Q: Neurons release injured mitochondria as
'Help-Me' signaling after ischemic stroke. Front Aging Neurosci.
14:7857612022. View Article : Google Scholar
|
|
158
|
Jiang D, Gao F, Zhang Y, Wong DS, Li Q,
Tse HF, Xu G, Yu Z and Lian Q: Mitochondrial transfer of
mesenchymal stem cells effectively protects corneal epithelial
cells from mitochondrial damage. Cell Death Dis. 7:e24672016.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Hasan-Olive MM, Enger R, Hansson HA,
Nagelhus EA and Eide PK: Pathological mitochondria in neurons and
perivascular astrocytic endfeet of idiopathic normal pressure
hydrocephalus patients. Fluids Barriers CNS. 16:392019. View Article : Google Scholar :
|
|
160
|
Guo W, Liu W, Chen Z, Gu Y, Peng S, Shen
L, Shen Y, Wang X, Feng GS, Sun Y and Xu Q: Tyrosine phosphatase
SHP2 negatively regulates NLRP3 inflammasome activation via
ANT1-dependent mitochondrial homeostasis. Nat Commun. 8:21682017.
View Article : Google Scholar :
|
|
161
|
Aoki Y, Huang Z, Thomas SS, Bhide PG,
Huang I, Moskowitz MA and Reeves SA: Increased susceptibility to
ischemia-induced brain damage in transgenic mice overexpressing a
dominant negative form of SHP2. FASEB J. 14:1965–1973. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Zou X, Xie L, Wang W, Zhao G, Tian X and
Chen M: FK866 alleviates cerebral pyroptosis and inflammation
mediated by Drp1 in a rat cardiopulmonary resuscitation model. Int
Immunopharmacol. 89:1070322020. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Dong J, Bobe G, Guan Y, Li G, Zuo R, Shu
X, Wang Y, Sun X, Chen X and Li X: Mitochondrial membrane protein
mitofusin 2 as a potential therapeutic target for treating free
fatty acid-induced hepatic inflammation in dairy cows during early
lactation. J Dairy Sci. 103:5561–5574. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Peng C, Rao W, Zhang L, Wang K, Hui H,
Wang L, Su N, Luo P, Hao YL, Tu Y, et al: Mitofusin 2 ameliorates
hypoxia-induced apoptosis via mitochondrial function and signaling
pathways. Int J Biochem Cell Biol. 69:29–40. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Wang X, Chen T, Ma X, Huang W, Huang Q,
Liu K and Liang H: Progress on nuclear factor-E2 related factor 2
transcription factors in sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi
Xue. 30:810–814. 2018.In Chinese. PubMed/NCBI
|
|
166
|
Zhao C, Gillette DD, Li X, Zhang Z and Wen
H: Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3
and AIM2 inflammasome activation. J Biol Chem. 289:17020–17029.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Anandhan A, Nguyen N, Syal A, Dreher LA,
Dodson M, Zhang DD and Madhavan L: NRF2 loss accentuates
Parkinsonian pathology and behavioral dysfunction in human
α-synuclein overexpressing mice. Aging Dis. 12:964–982. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu
S and Kong AN: Activation of Nrf2-antioxidant signaling attenuates
NFkappaB-inflammatory response and elicits apoptosis. Biochem
Pharmacol. 76:1485–1489. 2008. View Article : Google Scholar
|
|
169
|
Xu X, Zhang L, Ye X, Hao Q, Zhang T, Cui G
and Yu M: Nrf2/ARE pathway inhibits ROS-induced NLRP3 inflammasome
activation in BV2 cells after cerebral ischemia reperfusion.
Inflamm Res. 67:57–65. 2018. View Article : Google Scholar
|
|
170
|
Xu B, Zhang J, Strom J, Lee S and Chen QM:
Myocardial ischemic reperfusion induces de novo Nrf2 protein
translation. Biochim Biophys Acta. 1842:1638–1647. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Yu J, Wang WN, Matei N, Li X, Pang JW, Mo
J, Chen SP, Tang JP, Yan M and Zhang JH: Ezetimibe attenuates
oxidative stress and neuroinflammation via the AMPK/Nrf2/TXNIP
Pathway after MCAO in Rats. Oxid Med Cell Longev. 2020:47172582020.
View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Hou Y, Wang Y, He Q, Li L, Xie H, Zhao Y
and Zhao J: Nrf2 inhibits NLRP3 inflammasome activation through
regulating Trx1/TXNIP complex in cerebral ischemia reperfusion
injury. Behav Brain Res. 336:32–39. 2018. View Article : Google Scholar
|
|
173
|
Zhang C, He M, Ni L, He K, Su K, Deng Y,
Li Y and Xia H: The role of arachidonic acid metabolism in
myocardial ischemia-reperfusion injury. Cell Biochem Biophys.
78:255–265. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Shi Y, Peng XH, Li X, Luo GP and Wu MF:
Neuroprotective role of dexmedetomidine pretreatment in cerebral
ischemia injury via ADRA2A-mediated phosphorylation of ERK1/2 in
adult rats. Exp Ther Med. 16:5201–5209. 2018.PubMed/NCBI
|
|
175
|
Liu F, Lu J, Manaenko A, Tang J and Hu Q:
Mitochondria in Ischemic Stroke: New Insight and Implications.
Aging Dis. 9:924–937. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Wang X, Li R, Wang X, Fu Q and Ma S:
Umbelliferone ameliorates cerebral ischemia-reperfusion injury via
upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3
inflammasome. Neurosci Lett. 600:182–187. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Li Y, Li J, Li S, Li Y, Wang X, Liu B, Fu
Q and Ma S: Curcumin attenuates glutamate neurotoxicity in the
hippocampus by suppression of ER stress-associated TXNIP/NLRP3
inflammasome activation in a manner dependent on AMPK. Toxicol Appl
Pharmacol. 286:53–63. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Cao G, Jiang N, Hu Y, Zhang Y, Wang G, Yin
M, Ma X, Zhou K, Qi J, Yu B and Kou J: Ruscogenin attenuates
cerebral ischemia-induced blood-brain barrier dysfunction by
suppressing TXNIP/NLRP3 inflammasome activation and the MAPK
pathway. Int J Mol Sci. 17:14182016. View Article : Google Scholar :
|
|
179
|
Ishrat T, Mohamed IN, Pillai B, Soliman S,
Fouda AY, Ergul A, El-Remessy AB and Fagan SC:
Thioredoxin-interacting protein: A novel target for neuroprotection
in experimental thromboembolic stroke in mice. Mol Neurobiol.
51:766–778. 2015. View Article : Google Scholar
|
|
180
|
Ismael S, Nasoohi S, Yoo A, Ahmed HA and
Ishrat T: Tissue plasminogen activator promotes TXNIP-NLRP3
inflammasome activation after hyperglycemic stroke in mice. Mol
Neurobiol. 57:2495–2508. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Liu T, Wang W, Liu M, Ma Y, Mu F, Feng X,
Zhang Y, Guo C, Ding Y and Wen A: Z-Guggulsterone alleviated
oxidative stress and inflammation through inhibiting the
TXNIP/NLRP3 axis in ischemic stroke. Int Immunopharmacol.
89:1070942020. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Yang W, Chen X, Pan J, Ge H, Yin K, Wu Z,
Li X, Sha D and Xu Y: Malibatol A protects against brain injury
through reversing mitochondrial dysfunction in experimental stroke.
Neurochem Int. 80:33–40. 2015. View Article : Google Scholar
|
|
183
|
Gao XJ, Xie GN, Liu L, Fu ZJ, Zhang ZW and
Teng LZ: Sesamol attenuates oxidative stress, apoptosis and
inflammation in focal cerebral ischemia/reperfusion injury. Exp
Ther Med. 14:841–847. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Lu Y, Xiao G and Luo W: Minocycline
suppresses NLRP3 inflammasome activation in experimental ischemic
stroke. Neuroimmunomodulation. 23:230–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Qiu J, Wang M, Zhang J, Cai Q, Lu D, Li Y,
Dong Y, Zhao T and Chen H: The neuroprotection of Sinomenine
against ischemic stroke in mice by suppressing NLRP3 inflammasome
via AMPK signaling. Int Immunopharmacol. 40:492–500. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Peng J, Deng X, Huang W, Yu JH, Wang JX,
Wang JP, Yang SB, Liu X, Wang L, Zhang Y, et al: Irisin protects
against neuronal injury induced by oxygen-glucose deprivation in
part depends on the inhibition of ROS-NLRP3 inflammatory signaling
pathway. Mol Immunol. 91:185–194. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Qin YY, Li M, Feng X, Wang J, Cao L, Shen
XK, Chen J, Sun M, Sheng R, Han F and Qin ZH: Combined NADPH and
the NOX inhibitor apocynin provides greater anti-inflammatory and
neuroprotective effects in a mouse model of stroke. Free Radic Biol
Med. 104:333–345. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Safakheil M and Safakheil H: The effect of
exosomes derived from bone marrow stem cells in combination with
rosuvastatin on functional recovery and neuroprotection in rats
after ischemic stroke. J Mol Neurosci. 70:724–737. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Barakat W, Fahmy A, Askar M and
El-Kannishy S: Effectiveness of arginase inhibitors against
experimentally induced stroke. Naunyn Schmiedebergs Arch Pharmacol.
391:603–612. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Wang Y, Guan X, Gao CL, Ruan W, Zhao S,
Kai G, Li F and Pang T: Medioresinol as a novel PGC-1α activator
prevents pyroptosis of endothelial cells in ischemic stroke through
PPARα-GOT1 axis. Pharmacol Res. 169:1056402021. View Article : Google Scholar
|
|
191
|
Hu J, Zeng C, Wei J, Duan F, Liu S, Zhao Y
and Tan H: The combination of Panax ginseng and Angelica sinensis
alleviates ischemia brain injury by suppressing NLRP3 inflammasome
activation and microglial pyroptosis. Phytomedicine. 76:1532512020.
View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Yao Z, Liu N, Zhu X, Wang L, Zhao Y, Liu
Q, Gao C and Li J: Subanesthetic isoflurane abates ROS-activated
MAPK/NF-κB signaling to repress ischemia-induced microglia
inflammation and brain injury. Aging (Albany NY). 12:26121–26139.
2020. View Article : Google Scholar
|
|
193
|
Lin KC, Chen KH, Wallace CG, Chen YL, Ko
SF, Lee MS and Yip HK: Combined therapy with hyperbaric oxygen and
melatonin effectively reduce brain infarct volume and preserve
neurological function after acute ischemic infarct in rat. J
Neuropathol Exp Neurol. 78:949–960. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Yang M, Lv Y, Tian X, Lou J, An R, Zhang
Q, Li M, Xu L and Dong Z: Neuroprotective effect of β-caryophyllene
on cerebral ischemia-reperfusion injury via regulation of
necroptotic neuronal death and inflammation: In vivo and in vitro.
Front Neurosci. 11:5832017. View Article : Google Scholar
|
|
195
|
Zhong KL, Lu MY, Liu F, Mei Y, Zhang XJ,
Zhang H, Zan J, Sun XO and Tan W: Isosteviol sodium protects neural
cells against hypoxia-induced apoptosis through inhibiting MAPK and
NF-κB pathways. J Stroke Cerebrovasc Dis. 28:175–184. 2019.
View Article : Google Scholar
|
|
196
|
Turovskaya MV, Gaidin SG, Mal'Tseva VN,
Zinchenko VP and Turovsky EA: Taxifolin protects neurons against
ischemic injury in vitro via the activation of antioxidant systems
and signal transduction pathways of GABAergic neurons. Mol Cell
Neurosci. 96:10–24. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Zhao P, Chang RY, Liu N, Wang J, Zhou R,
Qi X, Liu Y, Ma L, Niu Y, Sun T, et al: Neuroprotective effect of
oxysophocarpine by modulation of MAPK pathway in rat hippocampal
neurons subject to oxygen-glucose deprivation and reperfusion. Cell
Mol Neurobiol. 38:529–540. 2018. View Article : Google Scholar
|
|
198
|
Wu D, Chen Y, Sun Y, Gao Q, Li H, Yang Z,
Wang Y, Jiang X and Yu B: Target of MCC950 in Inhibition of NLRP3
inflammasome activation: A literature review. Inflammation.
43:17–23. 2020. View Article : Google Scholar
|
|
199
|
Coll RC, Hill JR, Day CJ, Zamoshnikova A,
Boucher D, Massey NL, Chitty JL, Fraser JA, Jennings MP, Robertson
AAB and Schroder K: MCC950 directly targets the NLRP3
ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol.
15:556–559. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Jiao J, Zhao G, Wang Y, Ren P and Wu M:
MCC950, a selective inhibitor of NLRP3 inflammasome, reduces the
inflammatory response and improves neurological outcomes in mice
model of spinal cord injury. Front Mol Biosci. 7:372020. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Joaquim LS, Danielski LG, Bonfante S,
Biehl E, Mathias K, Denicol T, Bagio E, Lanzzarin EV, Machado RS,
Bernades GC, et al: NLRP3 inflammasome activation increases brain
oxidative stress after transient global cerebral ischemia in rats.
Int J Neurosci. 1–14. 2021.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Chen H, Guan B, Chen S, Yang D and Shen J:
Peroxynitrite activates NLRP3 inflammasome and contributes to
hemorrhagic transformation and poor outcome in ischemic stroke with
hyperglycemia. Free Radic Biol Med. 165:171–183. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Dwivedi DK and Jena GB: NLRP3 inhibitor
glibenclamide attenuates high-fat diet and streptozotocin-induced
non-alcoholic fatty liver disease in rat: Studies on oxidative
stress, inflammation, DNA damage and insulin signalling pathway.
Naunyn Schmiedebergs Arch Pharmacol. 393:705–716. 2020. View Article : Google Scholar
|
|
204
|
Zhu S, Gao X, Huang K, Gu Y, Hu Y, Wu Y,
Ji Z, Wang Q and Pan S: Glibenclamide enhances the therapeutic
benefits of early hypothermia after severe stroke in rats. Aging
Dis. 9:685–695. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Gueven N, Ravishankar P, Eri R and Rybalka
E: Idebenone: When an antioxidant is not an antioxidant. Redox
Biol. 38:1018122021. View Article : Google Scholar
|
|
206
|
Jiang W, Geng H, Lv X, Ma J, Liu F, Lin P
and Yan C: Idebenone Protects against atherosclerosis in
apolipoprotein E-Deficient mice via activation of the
SIRT3-SOD2-mtROS pathway. Cardiovasc Drugs Ther. 35:1129–1145.
2021. View Article : Google Scholar
|
|
207
|
Akopova O, Kolchinskaya L, Nosar V,
Mankovska I and Sagach V: Diazoxide affects mitochondrial
bioenergetics by the opening of mKATP channel on submicromolar
scale. BMC Mol Cell Biol. 21:312020. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Liu D, Lu C, Wan R, Auyeung WW and Mattson
MP: Activation of mitochondrial ATP-dependent potassium channels
protects neurons against ischemia-induced death by a mechanism
involving suppression of Bax translocation and cytochrome c
release. J Cereb Blood Flow Metab. 22:431–443. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Lei X, Lei L, Zhang Z and Cheng Y:
Diazoxide inhibits of ER stressmediated apoptosis during
oxygenglucose deprivation in vitro and cerebral ischemiareperfusion
in vivo. Mol Med Rep. 17:8039–8046. 2018.PubMed/NCBI
|
|
210
|
Mishra SR, Mahapatra KK, Behera BP, Patra
S, Bhol CS, Panigrahi DP, Praharaj PP, Singh A, Patil S, Dhiman R
and Bhutia SK: Mitochondrial dysfunction as a driver of NLRP3
inflammasome activation and its modulation through mitophagy for
potential therapeutics. Int J Biochem Cell Biol. 136:1060132021.
View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Nógrádi B, Nyúl-Tóth Á, Kozma M, Molnár K,
Patai R, Siklós L, Wilhelm I and Krizbai IA: Upregulation of
nucleotide-binding oligomerization Domain-, LRR- and pyrin
domain-containing protein 3 in motoneurons following peripheral
nerve injury in mice. Front Pharmacol. 11:5841842020. View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Gong Z, Pan J, Shen Q, Li M and Peng Y:
Mitochondrial dysfunction induces NLRP3 inflammasome activation
during cerebral ischemia/reperfusion injury. J Neuroinflammation.
15:2422018. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Kondoh T, Uneyama H, Nishino H and Torii
K: Melatonin reduces cerebral edema formation caused by transient
forebrain ischemia in rats. Life Sci. 72:583–590. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Kilic E, Caglayan B and Caglar BM:
Physiological and pharmacological roles of melatonin in the
pathophysiological components of cellular injury after ischemic
stroke. Turk J Med Sci. 50:1655–1664. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Fan W, He Y, Guan X, Gu W, Wu Z, Zhu X,
Huang F and He H: Involvement of the nitric oxide in
melatonin-mediated protection against injury. Life Sci.
200:142–147. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Yang Y, Jiang S, Dong Y, Fan C, Zhao L,
Yang X, Li J, Di S, Yue L, Liang G, et al: Melatonin prevents cell
death and mitochondrial dysfunction via a SIRT1-dependent mechanism
during ischemic-stroke in mice. J Pineal Res. 58:61–70. 2015.
View Article : Google Scholar
|
|
217
|
Ramos E, Patino P, Reiter RJ, Gil-Martín
E, Marco-Contelles J, Parada E, de Los Rios C, Romero A and Egea J:
Ischemic brain injury: New insights on the protective role of
melatonin. Free Radic Biol Med. 104:32–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Paredes SD, Rancan L, Kireev R, González
A, Louzao P, González P, Rodríguez-Bobada C, García C, Vara E and
Tresguerres JA: Melatonin counteracts at a transcriptional level
the inflammatory and apoptotic response secondary to ischemic brain
injury induced by middle cerebral artery blockade in aging rats.
Biores Open Access. 4:407–416. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Wang X, Figueroa BE, Stavrovskaya IG,
Zhang Y, Sirianni AC, Zhu S, Day AL, Kristal BS and Friedlander RM:
Methazolamide and melatonin inhibit mitochondrial cytochrome C
release and are neuroprotective in experimental models of ischemic
injury. Stroke. 40:1877–1885. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Gilani GS, Nimal RW, Mueller R and Mazza
G: Effects of source of protein and supplementary extracted
isoflavones and anthocyanins on longevity of Stroke-prone
Spontaneously Hypertensive (SHRSP) rats. J Toxicol Sci. 34:335–341.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Song F, Zhu Y, Shi Z, Tian J, Deng X, Ren
J, Andrews MC, Ni H, Ling W and Yang Y: Plant food anthocyanins
inhibit platelet granule secretion in hypercholesterolaemia:
Involving the signalling pathway of PI3K-Akt. Thromb Haemost.
112:981–991. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Feng R, Ni HM, Wang SY, Tourkova IL,
Shurin MR, Harada H and Yin XM: Cyanidin-3-rutinoside, a natural
polyphenol antioxidant, selectively kills leukemic cells by
induction of oxidative stress. J Biol Chem. 282:13468–13476. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
223
|
Dreiseitel A, Schreier P, Oehme A, Locher
S, Rogler G, Piberger H, Hajak G and Sand PG: Inhibition of
proteasome activity by anthocyanins and anthocyanidins. Biochem
Biophys Res Commun. 372:57–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Cai Y, Li X, Pan Z, Zhu Y, Tuo J, Meng Q,
Dai G, Yang G and Pan Y: Anthocyanin ameliorates hypoxia and
ischemia induced inflammation and apoptosis by increasing
autophagic flux in SH-SY5Y cells. Eur J Pharmacol. 883:1733602020.
View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Pan Z, Cui M, Dai G, Yuan T, Li Y, Ji T
and Pan Y: Protective effect of anthocyanin on neurovascular unit
in cerebral ischemia/reperfusion injury in rats. Front Neurosci.
12:9472018. View Article : Google Scholar
|
|
226
|
Liobikas J, Skemiene K, Trumbeckaite S and
Borutaite V: Anthocyanins in cardioprotection: A path through
mitochondria. Pharmacol Res. 113:808–815. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Min J, Yu SW, Baek SH, Nair KM, Bae ON,
Bhatt A, Kassab M, Nair MG and Majid A: Neuroprotective effect of
cyanidin-3-O-glucoside anthocyanin in mice with focal cerebral
ischemia. Neurosci Lett. 500:157–161. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Cui HX, Chen JH, Li JW, Cheng FR and Yuan
K: Protection of anthocyanin from myrica rubra against cerebral
ischemia-reperfusion injury via modulation of the TLR4/NF-κB and
NLRP3 pathways. Moleculs. 23:17882018. View Article : Google Scholar
|
|
229
|
Gutierrez-Vargas JA, Munera A and
Cardona-Gomez GP: CDK5 knockdown prevents hippocampal degeneration
and cognitive dysfunction produced by cerebral ischemia. J Cereb
Blood Flow Metab. 35:1937–1949. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Xue LX, Zhang T, Zhao YW, Geng Z, Chen JJ
and Chen H: Efficacy and safety comparison of DL-3-n-butylphthalide
and Cerebrolysin: Effects on neurological and behavioral outcomes
in acute ischemic stroke. Exp Ther Med. 11:2015–2020. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Fagan SC, Waller JL, Nichols FT, Edwards
DJ, Pettigrew LC, Clark WM, Hall CE, Switzer JA, Ergul A and Hess
DC: Minocycline to improve neurologic outcome in stroke (MINOS): A
dose-finding study. Stroke. 41:2283–2287. 2010. View Article : Google Scholar : PubMed/NCBI
|
